We are live on
!
Find out more
FCM
Farallon Capital Management Portfolio holdings
AUM
$17.5B
1-Year Est. Return
50.95%
This Fund
S&P 500
This Quarter
Est. Return
-7.99%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$18.4B
AUM Growth
-$2.28B
(-11%)
Cap. Flow
-$623M
Cap. Flow
% of AUM
-3.38%
Top 10 Holdings %
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$314M |
| 2 |
Dynatrace
DT
|
+$312M |
| 3 |
CoStar Group
CSGP
|
+$301M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$249M |
| 5 |
Clarivate
CLVT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$411M |
| 2 |
RTX Corp
RTX
|
+$335M |
| 3 |
CERN
Cerner Corp
CERN
|
+$312M |
| 4 |
Broadcom
AVGO
|
+$257M |
| 5 |
PLAN
Anaplan, Inc.
PLAN
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.85% |
| 2 | Technology | 17.59% |
| 3 | Financials | 14.68% |
| 4 | Industrials | 9.18% |
| 5 | Communication Services | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $1.4B | 7.57% |
3,700,000
-2,011,000
| -35% | -$824M |
|
2
IQVIA
IQV
$34.9B
| $697M | 3.78% |
3,213,582
+96,000
| +3% | +$20.8M |
|
3
Thermo Fisher Scientific
TMO
$209B
| $675M | 3.66% |
1,242,459
+18,600
| +2% | +$10.2M |
|
4
TransUnion
TRU
$14.7B
| $597M | 3.24% |
7,462,996
+1,274,500
| +21% | +$110M |
|
5
Boston Scientific
BSX
$66.2B
| $561M | 3.04% |
15,047,257
-693,000
| -4% | -$28.2M |
|
6
Aramark
ARMK
$15.1B
| $490M | 2.66% |
22,171,104
-653,416
| -3% | -$16.1M |
|
7
Howmet Aerospace
HWM
$116B
| $435M | 2.36% |
13,837,353
+211,000
| +2% | +$7.23M |
|
8
Elevance Health
ELV
$81.8B
| $399M | 2.16% |
826,482
+57,707
| +8% | +$28.5M |
|
9
Centene
CNC
$31.3B
| $367M | 1.99% |
4,341,194
+288,850
| +7% | +$24M |
|
10
Mastercard
MA
$473B
| $363M | 1.97% |
1,151,271
+74,682
| +7% | +$25.7M |
|
11
Full Truck Alliance
YMM
$9.56B
| $359M | 1.95% |
39,675,743
+16,497,000
| +71% | +$112M |
|
|
12
Clarivate
CLVT
$1.3B
| $340M | 1.85% |
24,557,800
+15,844,372
| +182% | +$237M |
|
13
Wabtec
WAB
$50.9B
| $327M | 1.78% |
3,989,933
-917,997
| -19% | -$81.8M |
|
14
Microsoft
MSFT
$2.86T
| $327M | 1.77% |
1,272,878
-13,200
| -1% | -$3.58M |
|
15
Alphabet (Google) Class C
GOOG
$3.9T
| $314M | 1.7% |
2,868,140
-488,000
| -15% | -$57.7M |
|
|
16
Dynatrace
DT
$12B
| $309M | 1.68% |
+7,847,000
| New | +$312M |
|
17
AstraZeneca
AZN
$261B
| $306M | 1.66% |
2,314,981
+526,889
| +29% | +$69.1M |
|
|
ATVI
18
DELISTED
Activision Blizzard
ATVI
| $302M | 1.64% |
3,880,000
+530,000
| +16% | +$41.2M |
|
|
19
CoStar Group
CSGP
$11.3B
| $300M | 1.63% |
+4,963,185
| New | +$301M |
|
20
Equifax
EFX
$20.3B
| $296M | 1.6% |
1,617,357
+424,654
| +36% | +$85M |
|
|
SJR
21
DELISTED
Shaw Communications Inc.
SJR
| $292M | 1.58% |
9,917,000
-211,000
| -2% | -$6.11M |
|
22
Salesforce
CRM
$133B
| $290M | 1.57% |
1,758,938
+600
| +0% | +$106K |
|
23
Visa
V
$673B
| $288M | 1.56% |
1,462,810
+170,957
| +13% | +$35.3M |
|
24
Meta Platforms (Facebook)
META
$1.53T
| $287M | 1.56% |
1,781,040
-283,700
| -14% | -$54.7M |
|
|
BHVN
25
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $284M | 1.54% |
+1,947,820
| New | +$249M |
|
Similar funds
BBA
MCM
LA
CM
ASRS
PP
VMPIC
HNB
Farallon Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Farallon Capital Management held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Farallon Capital Management withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Farallon Capital Management opened a new position in Twitter, Inc. worth $274M.
- Farallon Capital Management's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
- Farallon Capital Management added most to Clarivate in Q2 2022, an estimated $237M increase.
- Farallon Capital Management's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
- Farallon Capital Management fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
- Farallon Capital Management's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
- Farallon Capital Management opened 22 new positions and closed 30 in Q2 2022.
- Farallon Capital Management's portfolio value fell 11% quarter-over-quarter to $18.4B.
Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.